Perceptive Advisors - TURNING POINT THERAPEUTICS I ownership

TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 196 filers reported holding TURNING POINT THERAPEUTICS I in Q4 2020. The put-call ratio across all filers is 0.56 and the average weighting 0.3%.

Quarter-by-quarter ownership
Perceptive Advisors ownership history of TURNING POINT THERAPEUTICS I
ValueSharesWeighting
Q3 2020$28,819,000
+35.2%
329,8900.0%0.42%
+22.0%
Q2 2020$21,308,000
+38.0%
329,890
-5.7%
0.34%
-14.2%
Q1 2020$15,441,000
-43.3%
349,890
-20.0%
0.40%
-25.7%
Q4 2019$27,245,000
+21.3%
437,390
-26.8%
0.54%
-10.6%
Q3 2019$22,454,000
+29.8%
597,190
+40.5%
0.60%
+52.4%
Q2 2019$17,296,000424,9680.40%
Other shareholders
TURNING POINT THERAPEUTICS I shareholders Q4 2020
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 2,737,297$176,802,0006.75%
MPM BioImpact LLC 308,686$19,938,0005.30%
Burrage Capital Management LLC 77,172$4,985,0003.49%
Orbimed Advisors 2,745,327$177,321,0002.50%
Parkman Healthcare Partners LLC 110,318$7,125,0002.01%
SECTORAL ASSET MANAGEMENT INC 284,486$18,375,0001.69%
First Light Asset Management, LLC 192,829$12,455,0001.45%
Asymmetry Capital Management, L.P. 22,608$1,460,0001.12%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 35,000$2,236,0000.74%
Prosight Management, LP 25,602$1,654,0000.71%
View complete list of TURNING POINT THERAPEUTICS I shareholders